| THE UNIVERSITY OF SYDNEY Patent applications |
| Patent application number | Title | Published |
|---|
| 20110196088 | POLYMER PRODUCT AND INTERFACIAL POLYMERISATION PROCESS USING RAFT AGENT - The invention provides a method of polymerising monomer to form polymer at the surface of solid particulate material, said method comprising: providing a dispersion of said solid particulate material in a continuous hydrophilic liquid phase, said dispersion comprising a hydrophilic RAFT agent as a stabiliser for said solid particulate material, and said continuous hydrophilic liquid phase comprising one or more ethylenically unsaturated monomers; and polymerising said one or more ethylenically unsaturated monomers under the control of said hydrophilic RAFT agent to thereby form polymer at the surface of said solid particulate material. | 08-11-2011 |
| 20110111005 | BIOCOMPATIBLE MATERIAL AND USES THEREOF - The present invention relates to a biocompatible ceramic material comprising Sr, Mg or Ba doped Hardystonite (Ca | 05-12-2011 |
| 20110070028 | REVERSE OSMOSIS IRRIGATION - A plant watering device is disclosed. The device has a preferentially water permeable membrane arranged to separate a supply of water from a root system of a plant. The membrane is arranged to allow water to permeate to water the roots. | 03-24-2011 |
| 20100324677 | BIOCOMPATIBLE MATERIAL AND USES THEREOF - The present invention relates to a biocompatible ceramic material comprising Baghdadite (Ca | 12-23-2010 |
| 20100303321 | System and Method for Conducting Multiplexed Electrical Impedance Tomography - A method is provided for taking electrical impedance tomography measurements using multiple electrodes located at selected positions external to a volume of a subject body. Multiple orthogonal or near-orthogonal signals are introduced simultaneously by way of selected different electrodes and resultant predetermined responses (if any) at receiving electrodes are recorded or determined. The signals are encoded using the technique of code division multiplexing and received signals at each receiving electrode are cross-correlated with original signals to determine the contribution of each original signal to a composite received signal. The invention also relates to apparatus suitable for use in applying a method. | 12-02-2010 |
| 20100267611 | TREATMENT OF METABOLIC DISEASE - The invention relates to metabolic disease, including non alcoholic fatty liver disease, to risk factors associated with same and to phospholipid-containing compositions. | 10-21-2010 |
| 20100247101 | HIGH FREQUENCY OPTICAL PROCESSING - This invention concerns a high frequency optical processor suitable for time-division demultiplexing and channel dropping data signals at bit rates of 80-160 Gb/s and beyond, and for carving high frequency pulse streams with low duty cycle from an unmodulated laser source. In further aspects the invention concerns methods for using the high frequency optical processor. In particular the invention comprises a high frequency optical processor, comprising a Mach-Zehnder amplitude modulator (MZM) embedded in a fibre mirror loop in which the loop input and output are joined by a polarization maintaining coupler. | 09-30-2010 |
| 20100227372 | BIOLOGICAL FUNCTIONALISATION OF SUBSTRATES - The invention relates to an activated metallic, semiconductor, polymer, composite and/or ceramic substrate, the substrate being bound through a mixed or graded interface to a hydrophilic polymer surface that is activated to enable direct covalent binding to a functional biological molecule, the polymer surface comprising a sub-surface that includes a plurality of cross-linked regions, as well as to such activated substrates that have been functionalised with a biological molecule and to devices comprising such functionalised substrates. Such substrates can be produced by a method comprising steps of: a. exposing a surface of the substrate to any or more of (i) to (iii): (i) plasma ion implantation with carbon containing species; (ii) co-deposition under conditions in which substrate material is deposited with carbon containing species while gradually reducing substrate material proportion and increasing carbon containing species proportion; (iii) deposition of a plasma polymer surface layer with energetic ion bombardment; incubating the surface treated according to step (a) with a desired biological molecule. | 09-09-2010 |
| 20100146652 | XENOBIOTIC RELATED INDUCTION OF GENE EXPRESSION - An isolated nucleic acid molecule comprising a nucleotide sequence encoding a transcriptional enhancer of cytochrome P450 (P450) CYP3A4 production or expression, and uses of the nucleic acid molecule for screening compounds for xenobiotic induction of CYP3A4 expression in cells and animals. | 06-10-2010 |
| 20100111867 | CARBORANE-PHOSPHONIUM COMPOUNDS AND THEIR USE IN BORON NEUTRON CAPTURE THERAPY AND IMAGING - The invention describes compounds for use in BCNT. These compounds comprise a carborane group coupled to a phosphorus containing group. The compounds may comprise a carborane group coupled to a phosphonium group. | 05-06-2010 |
| 20100067555 | TUNABLE OPTICAL SUPERCONTINUUM ENHANCEMENT - A method and apparatus for providing optical supercontinuum. The method comprises creating a spectrally narrow phase feature within a supercontinuum spectrum produced from a laser pulse that has been subjected to supercontinuum generation, thereby producing a modified supercontinuum spectrum, and propagating the modified supercontinuum spectrum through an optical waveguide that is suitable for supercontinuum generation, thereby further modifying the modified supercontinuum spectrum. The method may include modifying the modified supercontinuum spectrum by increasing its energy in a vicinity of the phase feature. | 03-18-2010 |
| 20100048750 | VESICULATED POLYMER PARTICLES - The invention provides a method of preparing an aqueous dispersion of vesiculated polymer particles, the method comprising: preparing a dispersion of polymerisable particles within a continuous aqueous phase, the polymerisable particles having a structure that is defined by an outer organic phase that comprises one or more ethylenically unsaturated monomers and surrounds an inner aqueous phase, said inner aqueous phase defining a single void within the polymerisable particle, wherein a RAFT agent functions as a stabiliser for the outer organic phase within the continuous aqueous phase, and wherein a RAFT agent functions as a stabiliser for the inner aqueous phase within the outer organic phase; and polymerising the one or more ethylenically unsaturated monomers under the control of a RAFT agent functioning as said stabiliser to form the aqueous dispersion of vesiculated polymer particles. | 02-25-2010 |
| 20100028362 | MODULATION OF T HELPER CELL-MEDIATED IMMUNE RESPONSES - Provided herein are methods for modulating one or more of a T-helper cell or monocyte lineage cell-mediated immune response in a subject, the method comprises administering to the subject an effective amount of a compound which binds to surface membrane immunoglobulin D (smIgD). Also provided are methods of diagnosis of one or more of a T-helper cell or monocyte lineage cell-mediated immune disease, and compositions and kits for use in such methods. | 02-04-2010 |
| 20100021440 | USE OF TROPOELASTIN FOR REPAIR OR RESTORATION OF TISSUE - The present invention relates to tropoelastin and to tissue repair and restoration using elastic materials. Disclosed is a process for producing an elastic material from tropoelastin including heating a solution of tropoelastin having an alkaline pH to form an elastic material from the tropoelastin in the solution. Also disclosed are elastic materials prepared according to this process and their applications. | 01-28-2010 |
| 20100016367 | BIS-PYRINIDIUM COMPOUNDS - A method of treating, inhibiting, or preventing an infection in a subject is described. The method comprises administering to the subject an effective amount of at least one bis-pyridinium compound. The bis-pyridinium compound comprises two aromatic ring structures. Each of the ring structures comprises a pyridine ring, and the ring structures are linked by a linker group of at least 8 atoms in length, said linker group being attached to the nitrogen atoms of the pyridine rings. At least one substituent on at least one of the ring structures is an alkyl group having at least 2 carbon atoms, and no substituent on either of the ring structures is —OH, —SH or an amine group. | 01-21-2010 |
| 20100004132 | MODIFIED INORGANINC MATERIALS - A method of conditioning a tubular clay material to enable its loading with an active, the method comprising the step of exposing the tubular clay material to a chemical agent in a manner such that the agent sorbs to a surface of the clay material that is internal of the tube, the chemical agent being selected such that, when the agent is sorbed to the clay material internal surface, the affinity of the tubular clay material for the active is altered. | 01-07-2010 |
| 20090311176 | 2-Arylpyrazolo[L,5-Alpha] Pyrimidin-3-YL Acetamide Derivatives as Ligands for Translocator Protein (18 Kda) - The invention provides compounds of formula (I) radiolabelled with | 12-17-2009 |
| 20090307785 | Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation - The invention relates to the generation of non-human transgenic animals comprising a reporter construct for producing a detectable amount of a reporter molecule operably linked to a transcriptional regulatory nucleic acid molecule from the human CYP3A4 gene located between the initiation of transcription site of the gene and a position located 13,000 nucleotides upstream from the site. The invention also relates to the use of these animals for determining the effect of a compound, particularly, but not exclusively, a xenobiotic or steroid, on the regulation of expression of the CYP3A4 gene in a human. | 12-10-2009 |
| 20090288181 | Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation - The invention relates to the generation of non-human transgenic animals comprising a reporter construct for producing a detectable amount of a reporter molecule operably linked to a transcriptional regulatory nucleic acid molecule from the human CYP3A4 gene located between the initiation of transcription site of the gene and a position located 13,000 nucleotides upstream from the site. The invention also relates to the use of these animals for determining the effect of a compound, particularly, but not exclusively, a xenobiotic or steroid, on the regulation of expression of the CYP3A4 gene in a human. | 11-19-2009 |
| 20090258979 | POLYMER PRODUCT AND INTERFACIAL POLYMERISATION PROCESS USING RAFT AGENT - The invention provides a method of polymerising monomer to form polymer at the surface of solid particulate material, said method comprising: providing a dispersion of said solid particulate material in a continuous hydrophilic liquid phase, said dispersion comprising a hydrophilic RAFT agent as a stabiliser for said solid particulate material, and said continuous hydrophilic liquid phase comprising one or more ethylenically unsaturated monomers; and polymerising said one or more ethylenically unsaturated monomers under the control of said hydrophilic RAFT agent to thereby form polymer at the surface of said solid particulate material. | 10-15-2009 |
| 20090151777 | Solar Absorptive Material For a Solar Selective Surface Coating - The present invention provides a solar absorptive material for a solar selective surface of an absorber of solar radiation. The solar absorptive material comprises a dispersed metallic material and a receiving the top surface boundary through which the solar radiation is received. Further, the solar absorptive material comprises a first region and a second region. The first region being located at a position closer to the receiving boundary than the second region and the first region has an average volume fraction of the dispersed metallic material that is larger than that of the second region. | 06-18-2009 |
| 20090130106 | DEMIBODIES: DIMERIZATION-ACTIVATED THERAPEUTIC AGENTS - The present invention relates generally to a set of synthetic immunointeractive molecules referred to herein as “demibodies” which are useful in targeting particular cells in a subject. More particularly, the present invention provides a set of demibodies wherein at least two molecules from within the set, each specific for a different antigen on a target cell, are required to interact together at the cell surface in order to form an active complex which directs demibody-mediated cellular or complement mediated cytotoxicity and/or reporter function and/or therapeutic activity. The demibodies of the present invention are useful in the targeting of particular cells such as cancer cells including leukemic cells, pathogens including malarial, bacterial and viral agents, and stem cells including embryonic and adult stem cells and pathogen cells. The present invention provides, therefore, methods of treatment, diagnosis and undertaking research and compositions comprising demibodies useful for same. | 05-21-2009 |
| 20090092550 | PORPHYRIN LINKED METRONIDAZOLE AGAINST GUM DISEASE: PORPHYROMONAS GINGIVALIS - The present invention relates generally to targeted molecular agents (TMAs) directed to a particular organism or group of organisms and uses thereof. More particularly, the present invention provides TMAs having a targeting moiety which comprises a natural or induced auxotrophic requirement of the particular organism as a vehicle for directing an agent linked to the moiety to be delivered to the target organism. The TMAs of the present invention are useful for targeting molecules such as antimicrobial agents and diagnostic agents to selected organisms. | 04-09-2009 |
| 20090092074 | AERONAUTICAL AD-HOC NETWORKS - A communications network architecture ( | 04-09-2009 |
| 20090050133 | REFLECTOR AND A RECEIVER FOR A SOLAR ENERGY COLLECTION SYSTEM - The present invention provides a reflector ( | 02-26-2009 |
| 20080275003 | Bis-Cationic Compounds and Use Thereof - The present invention relates to bis-cationic compounds comprising quaternary ammonium groups and/or quaternary phosphonium groups. The invention also relates to the use of bis-cationic compounds as Phospholipase B inhibitors and the use of bis cationic compounds for the treatment or prevention of microbial infection. | 11-06-2008 |
